Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy

Keyphrases

• Neoadjuvant Chemotherapy 100%
• Breast Carcinoma 100%
• Pathological Examination 100%
• Residual Cancer Burden 100%
• Lymph Node 50%
• Breast Cancer Patients 50%
• Breast 50%
• Calculator 25%
• Malignancy 25%
• Pathologist 25%
• Treatment Response 25%
• I-SPY 25%
• Reporting System 25%
• Neoadjuvant 25%
• Neoadjuvant Therapy 25%
• Breast Cancer Risk 25%
• English Language 25%
• Surgical Treatment 25%
• Staging System 25%
• Web-based System 25%
• American Joint Committee on Cancer 25%
• Systemic Agents 25%
• Adaptive Randomization 25%
• Adjuvant Systemic Therapy 25%
• American Joint Committee on Cancer Staging System 25%
• Breast Specimen 25%
• Cancer Systems 25%
• Post-neoadjuvant 25%
• Neoadjuvant Systemic Therapy 25%
• Platform Trials 25%

Medicine and Dentistry

• Neoadjuvant Chemotherapy 100%
• Breast Carcinoma 100%
• Malignant Neoplasm 75%
• Breast Cancer 50%
• Neoplasm 50%
• Lymph Node 50%
• Joint Committee 50%
• Cancer 25%
• Clinician 25%
• Treatment Response 25%
• Systemic Therapy 25%
• Cancer Staging 25%
• Pathologist 25%
• Neoadjuvant Therapy 25%
• English (Language) 25%
• Adjuvant Therapy 25%